Tonix Pharmaceuticals Holding Corp.
TNXP
$17.82
$0.633.67%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 98.78M | 28.23M | 4.16M | 7.05M | 24.95M |
Total Receivables | 7.82M | 9.42M | 3.34M | -- | 199.00K |
Inventory | 8.41M | 8.27M | 9.46M | 12.35M | 14.15M |
Prepaid Expenses | 2.45M | 2.49M | 7.44M | 10.70M | 6.25M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 1.55M | 2.13M | 900.00K | -- | 2.23M |
Total Current Assets | 119.00M | 50.54M | 25.29M | 30.10M | 47.77M |
|
|||||
Total Current Assets | 119.00M | 50.54M | 25.29M | 30.10M | 47.77M |
Net Property, Plant & Equipment | 42.82M | 43.38M | 43.94M | 93.82M | 94.85M |
Long-term Investments | -- | -- | -- | 965.00K | 965.00K |
Goodwill | -- | -- | -- | 965.00K | 965.00K |
Total Other Intangibles | 120.00K | 120.00K | 120.00K | 9.51M | 9.74M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 951.00K | 951.00K | 961.00K | 960.00K | 1.13M |
Total Assets | 162.89M | 94.99M | 70.31M | 135.34M | 154.46M |
|
|||||
Total Accounts Payable | 4.55M | 3.94M | 10.41M | 6.65M | 3.78M |
Total Accrued Expenses | 7.01M | 4.32M | 4.81M | 10.73M | 8.74M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 3.09M | 3.10M | 3.10M | 3.10M | 2.62M |
Total Finance Division Other Current Liabilities | 3.66M | 3.83M | 3.73M | -- | 3.74M |
Total Other Current Liabilities | 3.66M | 3.83M | 3.73M | -- | 3.74M |
Total Current Liabilities | 18.31M | 15.18M | 22.04M | 20.48M | 18.88M |
|
|||||
Total Current Liabilities | 18.31M | 15.18M | 22.04M | 20.48M | 18.88M |
Long-Term Debt | 4.67M | 5.17M | 5.67M | 6.16M | 6.56M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 358.00K | 425.00K | 493.00K | 563.00K | 632.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | 22.86M |
Total Liabilities | 23.33M | 20.78M | 28.20M | 27.20M | 48.93M |
|
|||||
Common Stock & APIC | 870.51M | 783.05M | 736.72M | 723.98M | 706.42M |
Retained Earnings | -730.69M | -708.59M | -694.37M | -615.60M | -600.66M |
Treasury Stock & Other | -255.00K | -250.00K | -243.00K | -240.00K | -232.00K |
Total Common Equity | 139.56M | 74.21M | 42.10M | 108.14M | 105.53M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 139.56M | 74.21M | 42.10M | 108.14M | 105.53M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 139.56M | 74.21M | 42.10M | 108.14M | 105.53M |
|